ES2162794T3 - Compuestos farmaceuticos que contienen ametocaina. - Google Patents

Compuestos farmaceuticos que contienen ametocaina.

Info

Publication number
ES2162794T3
ES2162794T3 ES92903123T ES92903123T ES2162794T3 ES 2162794 T3 ES2162794 T3 ES 2162794T3 ES 92903123 T ES92903123 T ES 92903123T ES 92903123 T ES92903123 T ES 92903123T ES 2162794 T3 ES2162794 T3 ES 2162794T3
Authority
ES
Spain
Prior art keywords
ametocaine
compounds containing
pharmaceutical compounds
amethocaine
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92903123T
Other languages
English (en)
Inventor
David Graham Boardman
Kevin Maughan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew PLC
TJ Smith and Nephew Ltd
Original Assignee
Smith and Nephew PLC
TJ Smith and Nephew Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith and Nephew PLC, TJ Smith and Nephew Ltd filed Critical Smith and Nephew PLC
Application granted granted Critical
Publication of ES2162794T3 publication Critical patent/ES2162794T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

SE PRESENTA UN COMPUESTO ESTABLE DURANTE SU ALMACENAMIENTO PARA ANESTESIA TOPICA QUE COMPRENDE AMETOCAINA Y UNA SAL FARMACEUTICAMENTE ACEPTABLE PRESENTE EN UNA CANTIDAD ENTRE EL 1 Y EL 30% DEL COMPUESTO, DICHO COMPUESTO TIENE UN PH NO MENOR DE 7.0.
ES92903123T 1991-01-30 1992-01-29 Compuestos farmaceuticos que contienen ametocaina. Expired - Lifetime ES2162794T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919101986A GB9101986D0 (en) 1991-01-30 1991-01-30 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2162794T3 true ES2162794T3 (es) 2002-01-16

Family

ID=10689227

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92903123T Expired - Lifetime ES2162794T3 (es) 1991-01-30 1992-01-29 Compuestos farmaceuticos que contienen ametocaina.

Country Status (12)

Country Link
US (2) US5580901A (es)
EP (1) EP0522122B1 (es)
JP (1) JP2650781B2 (es)
AT (1) ATE204474T1 (es)
AU (1) AU652226B2 (es)
CA (1) CA2078885C (es)
DE (1) DE69232014T2 (es)
DK (1) DK0522122T3 (es)
ES (1) ES2162794T3 (es)
GB (2) GB9101986D0 (es)
WO (1) WO1992013533A1 (es)
ZA (1) ZA92607B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684681A5 (fr) * 1992-09-03 1994-11-30 Keane Jr & Cie Composition coricide.
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
ES2173485T3 (es) 1996-10-14 2002-10-16 Kowa Co Anestesico local para uso externo.
DE19713263C2 (de) 1997-03-29 1999-11-04 Carsten Goldschmidt Verwendung einer Procainhydrochlorid-Injektionslösung zur Entzündungshemmung
US20040077593A1 (en) * 2002-10-21 2004-04-22 Marron Susan M. Numbing gel for hair removal
ES2223277B1 (es) 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
EP1660101A4 (en) * 2003-08-21 2010-02-24 Access Pharma Inc LIQUID FORMULATIONS FOR THE PREVENTION AND TREATMENT OF SLAUGHTER DISEASES AND DISORDERS

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1954152A (en) * 1929-12-19 1934-04-10 Winthrop Chem Co Inc Anaesthetic and process of preparing it
US1889645A (en) * 1930-12-22 1932-11-29 Winthrop Chem Co Inc Beta-dimethylaminoethyl ester of para-butylamino-benzoic acid
US2132351A (en) * 1934-07-14 1938-10-04 Winthrop Chem Co Inc Stable aqueous solutions of subtances having an anesthetic effect
US3272700A (en) * 1963-10-03 1966-09-13 Sterling Drug Inc Stabilized aqueous solution of tetracaine salt
GB1275903A (en) * 1968-08-27 1972-06-01 Smith & Nephew Dispenser
US4248855A (en) * 1976-08-27 1981-02-03 Hydrophilics International, Inc. Pharmaceutical base salts
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
US4148874A (en) * 1977-06-13 1979-04-10 The Procter & Gamble Company Dermatological compositions
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
GB2163956B (en) * 1984-09-08 1988-03-30 Ile De France Percutaneous anaesthetic composition for topical application
JPS6191137A (ja) * 1984-10-11 1986-05-09 Kao Corp 外用薬剤組成物
US4599354A (en) * 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
GB8712518D0 (en) * 1987-05-28 1987-07-01 Univ Belfast Unit-dose film composition
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5002974A (en) * 1988-04-04 1991-03-26 Warner-Lambert Co. Anesthetic/skin moisturizing composition and method of preparing same
US5149320A (en) * 1988-04-11 1992-09-22 Dhaliwal Avtar S Composite anesthetic article and method of use
US5209724A (en) * 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
SE9102890D0 (sv) * 1991-10-07 1991-10-07 Hans Evers Insektsrepelleringsmedel

Also Published As

Publication number Publication date
JP2650781B2 (ja) 1997-09-03
EP0522122B1 (en) 2001-08-22
US5733930A (en) 1998-03-31
GB9101986D0 (en) 1991-03-13
CA2078885A1 (en) 1992-07-31
GB2258397B (en) 1994-11-09
GB2258397A (en) 1993-02-10
ATE204474T1 (de) 2001-09-15
AU1178792A (en) 1992-09-07
EP0522122A1 (en) 1993-01-13
WO1992013533A1 (en) 1992-08-20
US5580901A (en) 1996-12-03
CA2078885C (en) 2002-03-19
ZA92607B (en) 1992-12-30
JPH05505405A (ja) 1993-08-12
AU652226B2 (en) 1994-08-18
DE69232014D1 (de) 2001-09-27
DK0522122T3 (da) 2001-12-10
DE69232014T2 (de) 2002-05-29
GB9219079D0 (en) 1992-11-04

Similar Documents

Publication Publication Date Title
IL117356A (en) Controlled release matrix and pharmaceutical compositions for oral administration containing it
FI935380A (fi) S(+)-ibuprofeenia sisältäviä lääkeaineita
DK134185D0 (da) Anti-viralt aktive pyridazinaminer
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
NO991731D0 (no) Lokalanestetikum for utvortes bruk
ES8507444A1 (es) Un procedimiento para la preparacion de un derivado de un alcohol , -dihidropoliprenilico
ES2162794T3 (es) Compuestos farmaceuticos que contienen ametocaina.
ES2028917T3 (es) Un procedimiento para preparar una composicion farmaceutica inyectable estable.
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
JPS5781409A (en) External plaster
SE9301112D0 (sv) A new composition
ATE69053T1 (de) Carbapenemderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8004383L (sv) Farmaceutisk beredning for oral administrering och forfarande for dess framstellning
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
IE43848L (en) Pharmaceutical compositions
JPS5634624A (en) Central nervous system depressant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 522122

Country of ref document: ES